694 NC410 is a novel immunomedicine for the treatment of solid tumors

694 NC410 is a novel immunomedicine for the treatment of solid tumors

Bibliographic Details
Main Authors: Linde Meyaard, Stefan Willems, M Ines Pascoal Ramos, Emma de Ruiter, Ana Paucarmayta, Eline Elshof, Chang Song, Zachary Cusumano, Jason Bosiacki
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer
id doaj-d446716d60df4ee3b919ef6e9883f614
record_format Article
spelling doaj-d446716d60df4ee3b919ef6e9883f6142020-12-11T10:03:28ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0694694 NC410 is a novel immunomedicine for the treatment of solid tumorsLinde Meyaard0Stefan Willems1M Ines Pascoal Ramos2Emma de Ruiter3Ana Paucarmayta4Eline Elshof5Chang Song6Zachary Cusumano7Jason Bosiacki82 Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands 2University Medical Center, Utrecht, Utrecht, Netherlands2University Medical Center, Utrecht, Utrecht, Netherlands2University Medical Center, Utrecht, Utrecht, Netherlands1NextCure, Inc., Beltsville, MD, USA2University Medical Center, Utrecht, Utrecht, Netherlands1NextCure, Inc., Beltsville, MD, USA1NextCure, Inc., Beltsville, MD, USA1NextCure, Inc., Beltsville, MD, USA
collection DOAJ
language English
format Article
sources DOAJ
author Linde Meyaard
Stefan Willems
M Ines Pascoal Ramos
Emma de Ruiter
Ana Paucarmayta
Eline Elshof
Chang Song
Zachary Cusumano
Jason Bosiacki
spellingShingle Linde Meyaard
Stefan Willems
M Ines Pascoal Ramos
Emma de Ruiter
Ana Paucarmayta
Eline Elshof
Chang Song
Zachary Cusumano
Jason Bosiacki
694 NC410 is a novel immunomedicine for the treatment of solid tumors
Journal for ImmunoTherapy of Cancer
author_facet Linde Meyaard
Stefan Willems
M Ines Pascoal Ramos
Emma de Ruiter
Ana Paucarmayta
Eline Elshof
Chang Song
Zachary Cusumano
Jason Bosiacki
author_sort Linde Meyaard
title 694 NC410 is a novel immunomedicine for the treatment of solid tumors
title_short 694 NC410 is a novel immunomedicine for the treatment of solid tumors
title_full 694 NC410 is a novel immunomedicine for the treatment of solid tumors
title_fullStr 694 NC410 is a novel immunomedicine for the treatment of solid tumors
title_full_unstemmed 694 NC410 is a novel immunomedicine for the treatment of solid tumors
title_sort 694 nc410 is a novel immunomedicine for the treatment of solid tumors
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2020-11-01
work_keys_str_mv AT lindemeyaard 694nc410isanovelimmunomedicineforthetreatmentofsolidtumors
AT stefanwillems 694nc410isanovelimmunomedicineforthetreatmentofsolidtumors
AT minespascoalramos 694nc410isanovelimmunomedicineforthetreatmentofsolidtumors
AT emmaderuiter 694nc410isanovelimmunomedicineforthetreatmentofsolidtumors
AT anapaucarmayta 694nc410isanovelimmunomedicineforthetreatmentofsolidtumors
AT elineelshof 694nc410isanovelimmunomedicineforthetreatmentofsolidtumors
AT changsong 694nc410isanovelimmunomedicineforthetreatmentofsolidtumors
AT zacharycusumano 694nc410isanovelimmunomedicineforthetreatmentofsolidtumors
AT jasonbosiacki 694nc410isanovelimmunomedicineforthetreatmentofsolidtumors
_version_ 1724386613502410752

Similar Items